Answers are grounded in this paper and cite their sources.
An active compound might be released into the body in a controlled manner through encapsulation, thereby potentially prolonging its activity. This study aimed to produce microcapsules containing Curcuma longa extract, a medicinal plant with oncological applications, via spray drying. Sodium alginate was used as a carrier, and a mixture of calcium chloride and ionic liquid choline chloride was employed as a crosslinker. The cytotoxic properties of this extract, crosslinking agent, carrier, and microcapsules were determined using the MTT assay in non-tumor fibroblast cells (LLC-MK2) and human uterine tumor cells (SIHA). Scanning electron microscopy and Fourier-transform mid-infrared spectroscopy were utilized to assess encapsulation, while ultraviolet-visible spectroscopy was used to monitor release of the extract. Curcuma longa extract did not exert a cytotoxic effect on LLC-MK2 cells but inhibited proliferation of uterine SIHA tumor cells at 50 μg/ml (24 hr) and 100 μg/ml (48 or 72 hr). The carrier and crosslinker did not exhibit cytotoxic effects at any concentration or time point examined. The microcapsules with Curcuma longa extract ranged in size from 16.6 to 79.2 μm, with a mean of 40.24 μm, and exhibited cytotoxicity against SIHA cells at 48 hr (300 to 1000 μg/ml) and 72 hr (500 or 1000 μg/ml). Data demonstrated the feasibility of producing a potential uterine antitumor drug based on Curcuma longa and sodium alginate–choline chloride with controlled, efficient release.
No takes yet. Share an insight, caveat, or question.
Santos et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: